Repare Therapeutics says less than 2% of cash, equivalents held at SVB

In a regulatory filing, Repare Therapeutics (RPTX) announced that as of December 31, 2022, the company had cash, cash equivalents and marketable securities of $343.9M. As of March 9, the company had less than 2% of its cash, cash equivalents and marketable securities with Silicon Valley Bank (SIVB).